TAUB REBECCA sold 0.1% of their position (240.00 shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $132.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/13/2026ACC: 0001628280-26-001970
Director
Since Mar 2026
-240.00
Net shares
Net seller
$132.1K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
240.00 acquired · 480.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+240.00
Price / share
$15.80
Trade value
$3.79K
% of position
0.1%
1/9/2026
455.59K→455.83K
Common Stock
Direct
Shares
−40.00
Price / share
$545.79
Trade value
$21.83K
% of position
0.0%
1/9/2026
455.83K→455.79K
Common Stock
Direct
Shares
−200.00
Price / share
$551.24
Trade value
$110.25K
% of position
0.0%
1/9/2026
455.79K→455.59K
Total
Net shares
+0.00
Net value
-$128.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2026 | M · Option Exercise | +240.00 | $15.80 | $3.79K | 0.1% | 455.59K | 455.83K |
| Common Stock Direct | 1/9/2026 | S · Sale | −40.00 | $545.79 | $21.83K | 0.0% | 455.83K | 455.79K |
| Common Stock Direct | 1/9/2026 | S · Sale | −200.00 | $551.24 | $110.25K | 0.0% | 455.79K | 455.59K |
| Total | +0.00 | -$128.29K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
240.00 shares
Shares
−240.00
Strike price
15.80
Held after
0.00
Exercisable
—
1/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock240.00 shares | 1/9/2026 | M · Option Exercise | −240.00 | 15.80 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned655.54K
Total
655.54K indirect655.54K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 655.54K | Indirect |
| Total | 655.54K | 655.54K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported